award

Targeting EGFR mutant tyrosine kinase inhibitors (TKIs) resistant and drug-tolerant persister cells in non-small cell lung cancer (NSCLC)

  • Award Number: R50CA265307

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 09/21/2021

  • PERIOD OF PERFORMANCE END DATE: 08/31/2026